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Fve, a major fruiting body protein from Flammulina velutipes, a mushroom possessing 
immunomodulatory activity, stimulates lymphocyte mitogenesis, suppresses systemic 
anaphylaxis reactions and edema, enhances transcription of IL-2, IFN-g and TNF-a, and 
hemagglutinates RBCs.  It appears to be a lectin with specificity for complex cell surface 
carbohydrates. Fve is a non-covalently linked homodimer containing no Cys, His and Met. 
It shares sequence similarity only to the other Fungal Immunomodulatory Proteins (FIPs) 
LZ-8, Gts, Vvo and Vvl, all of unknown structure. The 1.7 Å structure of Fve solved by 
Single Anomalous Diffraction of NaBr-soaked crystals is novel: each monomer consists 
of an N-terminal a-helix followed by a fibronectin III (FNIII) fold. The FNIII fold is the 
first instance of “pseudo-h-type” topology – a transition between the seven b-stranded s-
type and the eight b-stranded h-type topologies. The structure suggests that dimerization, 
critical for the activity of FIPs, occurs by 3-D domain swapping of the N-terminal helices 
and is stabilized predominantly by hydrophobic interactions. The structure of Fve is the 
first in this lectin family, and the first of an FNIII domain-containing protein of fungal 
origin. 
Rhodocetin is a unique heterodimer consisting of a and b subunits of 133 and 129 
residues respectively.  The molecule, purified from the crude venom of the Malayan pit 
viper, Calloselasma rhodostoma, functions as an inhibitor of collagen induced platelet 
aggregation.  Rhodocetin has been shown to have activity only when present as a dimer.  
The dimer is formed without an inter-subunit disulfide bridge as observed with all the 
other Ca2+- dependent lectin-like proteins (CLPs).  The 1.9 Å resolution structure of 
rhodocetin is determined by molecular replacement.  The structure reveals the inter-
subunit interface which has compensatory interactions for forming the dimer in the 
absence of the disulfide bridge.  This is the first structure of a CLP without a disulfide 
connecting the subunits and thus represents a novel molecule which can help to 
understand a new set of protein-protein interactions. Further, unlike other CLPs, 
rhodocetin does not require metal ions for its functional activity. However, like other 
CLPs, rhodocetin also forms the heterodimer by domain swapping, in which the central 





































3D DOMAIN SWAPPING 
 
Protein oligomers have evolved because of their advantages over their monomers. These 
advantages include the possibility of allosteric control, higher local concentration of active 
sites, larger binding surfaces, new active sites at subunit interfaces, and economic ways to 
produce large protein interaction networks and molecular machines. However, the 
mechanisms for the evolution of oligomeric interfaces and for the assembly of oligomers 
during protein synthesis or refolding remain unclear. Different mechanisms have been 
proposed for the evolution of protein oligomers, among which is three-dimensional (3D) 
domain swapping (Liu and Eisenberg, 2002). 
 
Background of 3D domain swapping  
Experimentally, the existence of 3D domain swapping was established, and the term 
introduced, recently, in 1994, when Eisenberg and coworkers observed it for the first time 
by X-ray crystallography in diphtheria toxin (Bennett et al., 1994). This structure led to a 
series of elegant theoretical papers by Eisenberg and coworkers that proposed how and 
why domain swapping might occur and the potential biological implications. However, 
the concept of 3D domain swapping can be traced back 40 years. Bovine pancreatic 
ribonuclease (RNase A) forms dimers during lyophilization in acetic acid. Based on 
elegant chemical modification experiments, Crestfield et al., 1962 proposed that the dimer 
forms by exchanging the N-terminal fragments (Figure 1.1).This mechanism is essentially 




Figure 1.1. (A) RNase A monomer. (B) 3D domain swapped dimer formed by exchanging 







3D domain swapping definition 
3D domain swapping is a mechanism for forming oligomeric proteins from their 
monomers. In 3D domain swapping one domain of a multidomain, monomeric protein is 
replaced by the same domain from an identical protein chain. The result is an intertwined 
dimer or higher oligomer, with one domain of each subunit replaced by the identical 
domain from another subunit. The swapped "domain" can be as large as an entire tertiary, 
globular domain, or as small as an alpha-helix or a strand of a beta-sheet (Bennett et al., 
1994) (Figure 1.2).   
Domain-swapped proteins have a C-interface, generally with many specific 
interactions. The C-interface in the monomeric and dimeric states formed between 
domains is linked by a hinge loop. The length of the swapped domain varies greatly from 
a 150-residues globular domain in DT (Diphtheria toxin) to a single a-helix of only 15 
residues in BS-Rnase. 3D domain swapping could also create a new open interface in the 
domain-swapped protein that is not found in the monomeric form (Bennett et al., 1995).  
Proteins must have a flexible linker or hinge region to undergo domain swapping. 
These hinge regions allow conformational changes within a molecule which partially 
unfold and then find another similar open monomer. Obviously, the hinge region is the 
only element that has a different structure in the monomeric and 3D domain-swapped 
forms (Jaskolski et al., 2001). 
The phenomenon of 3D domain swapping has been studied by examining: (1) 
bona fide 3D domain-swapped proteins, the structures of whose monomeric and 
oligomeric forms have been characterized by X-ray diffraction or NMR, (2) pairs of 
proteins whose structures form intertwined 3D domain-swapped oligomers without a 
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Figure 1.2. Reproduced from Jaskolski et al., 2001. Cartoon illustration of dimer 
formation via 3D domain swapping.      
                                                                                                                                                                                                                               
                      
 
 6 
known closed monomer. If these proteins have homologs which form a closed monomer, 
these oligomers considered to be quasi-domain-swapped, and (3) intertwined oligomers 
that are reminiscent of 3D domain-swapped proteins, but for which no monomeric form is 
known (Schlunegger et al., 1997). 
 
Helpful definitions 
Swapped domain: A swapped domain in a protein oligomer is a globular domain that is 
intertwined with an identical protein chain, with the swapped domain having an 
environment essentially identical to that of the same domain in a protein. 
 
Hinge loop: A segment of a polypeptide chain that links the swapped domain to the rest of 
its subunit is a hinge loop. 
 
C-interface: A C-interface occurs between domains in  monomeric subunits. 
 
3D domain-swapped: A dimer with a two C-interface between two different subunits is a 
3D domain-swapped dimer. 
 
History of 3D domain swapping Diphtheria toxin    
The comparison of DT monomer with dimer reveals a mode for protein dimerization 
which is being called domain swapping. Diphtheria toxin (DT) is a 533-residues protein 
toxin secreted from a bacterium that causes diphtheria (Collier et al., 1975). DT has three 
domains: a catalytic domain (C), a transmembrane domain (T) and a receptor-binding 
domain (R) (Bennett et al., 1994). 
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The dimeric form of DT does not form spontaneously even at higher concentrations. 
However, DT can be induced to form dimers by freezing the protein in phosphate buffer, 
which causes a drop in pH from the neutral value to 3.6 (Van den berg et al., 1959). The 
decrease in pH converts monomeric DT into open monomers, which form a DT dimer at 
high concentration by swapping the globular domain (R domain) (Figure 1.3) (Bennett et 
al., 1994).  
The structure of monomer DT revealed the mechanism by which low pH could 
trigger changes in monomer DT and thereby forms an open monomer. The interdomain 
interface between the R domain and C domain is charged: (1) nine basic and three acidic 
residues on the R domain interface surface and (2) seven acidic residues on the C domain 
interface surface. There are three salt bridges stabilizing the interface at neutral pH. The 
decrease in pH causes protonation of acidic residues and disrupts the salt bridges. 
Furthermore, buried positive charges in the interface favor the formation of the open 
monomer. During the dimerization of DT, high oligomers were observed by size-
exclusion HPLC. These oligomers include trimers, tetramers and pentamers (Bennett et 
al., 1994).   
 
More than one domain swapping 
The most common feature for domain-swapped proteins is that they can exchange either 
the N-terminal or C-terminal domains. Recent results indicate that RNase A can form two 
types of dimers where one dimer is more abundant than the other one (Libonati et al., 
1996 and Gotte et al., 1999). The Structures of both dimers revealed that RNase A can 
have either N-terminal or C-terminal swapped dimers. The less abundant dimer is called 
 8 
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Figure 1.3. (A) DT monomer. The domain that can be swapped is highlighted in yellow. 
(B) DT dimer. The two subunits are blue and green. The residues having different 
conformations between monomer and dimer are in the hinge loops (red).   
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N-terminal swapped dimer (Liu et al., 1998) (Figure 1.4B) and the more abundant dimer 
is called C-terminal swapped dimer (Liu et al., 2001) (Figure 1.4C).   
Two types of RNase A trimers were also observed: (1) major trimer (Figure 1.4D) 
and (2) minor trimer (Figure 1.4E) (Liu et al., 2002). The major trimer is thought to form 
a linear trimer that is formed by simultaneously swapping its N-terminal helix with a 
second molecule and its C-terminal strand with a third molecule, while the minor trimer 
forms a cyclic trimer by swapping the C-terminal strands only. These hypotheses were 
initially tested by dissociation studies of trimer RNase A. The dissociation result was 
consistent with the prediction (Liu et al., 2002).  Furthermore, the crystal structure of the 
minor form revealed that the minor trimer is indeed cyclic and 3D domain-swapped at the 
C-terminal strand (Liu et al., 2002).  
RNase A can also form tetramers (Gotte et al., 1999). The structure of dimers and 
trimers allows hypothesizing the structure of tetramers. Two of these models are linear: 
(1) with two C-terminals and one N-terminal portions are swapped and (2) with two N-
terminals and one C-terminal portions are swapped. Another model is a combination of 
cyclic and linear trimers where both types of swapping occur. The last one is a cyclic 
tetramer where only the C-terminus is swapped (Liu and Eisenberg, 2002). 
 
Examples of 3D domain swapping 
Domain-swapped proteins are diverse in sequence, size, function and the way their 
domains are swapped. These domain-swapped proteins are grouped into three categorizes: 
(1) Bona fide, (2) quasi and (3) candidate for domain swapping (Table 1.1-1.3). In a 
sequence comparison study of about 40 domain-swapped proteins, Liu and Eisenberg 
(2002) concluded that a domain swapping protein cannot be predicted based 
 10 
 
Figure 1.4. Reproduced from Liu and Eisenberg, 2002. Ribbon diagrams of the structures 
of the RNase A monomer (A), the minor dimer (B), the major dimer (C), the major trimer 
model (D), and the minor trimer (E) . The N- and C-termini are labeled. The N-terminal 
helix and C-terminal strand that are swapped in the oligomers are colored in blue and red, 
respectively, in the monomer (A). Both types of swapping take in the major trimer model 
(D): The green subunit swaps the C-terminal strand with the red subunit and swaps the N-
terminal helix with blue subunit. 
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on the sequence of the protein. In addition, their studies showed that domain swapped 
proteins form various interactions at the C-interface such as hydrophobic interactions, 
hydrogen-bonding, electrostatic interaction including disulfide bridge interactions 
(Diederichs et al., 1991; Milburn et al., 1993; Knaus et al., 2001).  
The swapped domains also have diverse secondary structures as reported by Liu 
and Eisenberg (2002): Domain-swapped proteins can have a swapped domain with one a-
helix (BS-RNase, RNase A N-terminal swapped dimer), one b-strand (CksHs2 dimer, cro 
dimer), several a-helices (calbindin D9k, barnase), several b-strands (b-B2 crystallin, 
diphtheria toxin dimer), or a mixture of a-helixes and b-strandes (T7 gp 4 ring helicase, 
human cystatin C). The observed data shows that 3D domain swapping does not require or 
prefer certain types of secondary structures (Table 1.1-1.3). 
 
Single mutation induce 3D domain swapping 
Manipulation of a protein sequence has given insight into the factors governing 3D 
domain swapping. The studies of O’Neill et al., 2001a showed that conformational strain 
imposed by mutation in a 64 residue domain of Protein L (Ppl) causes 3D domain 
swapping.  
The 64 residue B1 domain of Protein L (Ppl) from Peptostreptococcus magnus, 
consists of a central a-helix packed against a four stranded b sheet formed by two b 
hairpins. The pseudo-wild-type Ppl structure (WT*) revealed that the first b turn with 
residue G15 has a positive f angle while the second b turn contains three residues (D53, 
K54 and G55) with positive f angles (O’Neill et al., 2001b). Positive f angles can induce 






















Structures of four mutants (V94A, G55A, K54G and G15A) were determined to study the 
effect of b turn mutants G55A, K54G and G15A, as well as core mutant V94A (O’Neill et 
al., 2001a).  
 
Core mutant V94A. The structure of Ppl (V94A) was determined to a resolution of 1.8 Å. 
The structure revealed that the asymmetric unit contained two monomers and one b-strand 
swapped dimer (Figure 1.5). While the mutant monomers maintain the wild type fold, the 
molecules B and D form a dimer through the exchange of their N-terminal strands 
(O’Neill et al., 2001a). In the V94A monomer, residues D53, K54 and G55 retained the 
strain as in the WT*, however all the strains are released in one of the dimeric molecule 
(B) (Figure 1.5). 
The hinge region (52-55) of the dimeric molecule B begins its rotation at A52 and 
completes its rotation at G55, while the hinge loop of the molecule D began it rotation at 
K54 and completed its rotation at G55. This back bone rotation allowed D53 of B to take a 
negative f angle while the molecule D retained the positive f angle of D53.  
The V94A mutation in Ppl was not expected to have a significant effect on the 
overall fold because the mutation was in the core region of the protein. However, 
structural determination of the protein revealed that V94A mutation formed an intertwined 
dimer by exchanging the N-terminal strand (O’Neill et al., 2001a). Furthermore, the 
structure of the domain-swapped dimer helps to uncover the domain swapping 
mechanism. In the second b-turn in Ppl, there are three consecutive positive f angles, in 
which two are non-glycines. Generally, non-glycine amino acids with positive f angles are 
energetically unfavorable. Because of this conformational strain, the N-terminal b-strand 
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Figure 1.5. The asymmetric unit contains two monomers (cyan and brown) and a domain-






springs open and releases the strain when the interaction is weakened in the close interface 
(O’Neill et al., 2001a). 
 
Mutant G55A. The V49A mutant structure suggests that there are two opposing 
components of free energy: (1) the free energy component that favors domain swapping as 
deserved in the strain of the second b-turn and (2) the free energy component that 
disfavors domain swapping as in the loss of entrophy upon dimer formation. Based on this 
observation, a domain-swapped dimer was predicted in G55A mutant because the 
mutation would increase the strain in the second b-turn.  
The structure of G55A mutant shows that the fourth b-strand is swapped in a 
similar manner as in V49A (Figure 1.6). All the angles in the hinge region (53-56) have a 
negative f value in mutant G55A, unlike molecule D of V49A mutant where it retains the 
positive f angle of D53. The Cb atom of A55 and its symmetry mate in the dimer are 3.9 Å 
apart and tilted toward each other to make stabilizing van der Walls contacts. Furthermore, 
the Cb atom of A55 does not clash with its backbone carbonyl oxygen (O’Neill et al., 
2001a). 
 
Mutant K54G. The K54G mutant was crystallized to see if relieving the strain caused by 
the clash between the Cb atom and backbone carbonyl oxygen in K54 would have any 
effect on the conformation of the second b-turn. The structure revealed little main chain 
movement in the second b-turn. This confirmed that stability of the protein was increased 
by eliminating the clash in K54. The f angle for D53, G54 and G55 remained positive. 





Figure 1.6. The G55A domain-swapped dimer. The Cb atom of A55 and its symmetry 















between the Cb atom and backbone carbonyl oxygen in K54 (O’Neill et al., 2001a).  
 
Mutant G15A. A mutation was introduced in the first b-turn to test whether increasing the 
strain in a b-turn would be sufficient to induce domain swapping. Unlike the second b-
turn, this b-turn contains only one residue, G15, with the positive f angle. The mutant 
structure was seen to be a monomer. Furthermore, the A15 residue retained the positive f 
angle but now is in the allowed region of Ramachandran plot. This observation suggests 
that strain alone in the b-turn is not sufficient to induce domain swapping (O’Neill et al., 
2001a). 
Free energy estimation shows that the mutant has a higher transition-state free-
energy barrier because the cost of removing the first b-strand from the b-sheet is 
considerably higher. Moreover, the free energy for domain swapping is higher for the first 
b-strand compared to the fourth b-strand since the energy gain from the release of strain in 
the second b-turn is much more higher than the strain release in the first b-turn (O’Neill et 
al., 2001a). 
 
Design of 3D domain-swapped molecule 
The several designed dimeric protein molecules and their well studied motifs have given 
us knowledge to design protein structures of open and closed monomers. These designed 
molecules can lead to a domain-swapped dimer or to domain-swapped oligomers 
depending on topology (Ogihara et al., 2001).  
To study the designing of domain-swapped entities, monomeric 3-helix bundles
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were utilized. The bundles are variants of designed 3-a-helical bundle called coil-Ser, 
whose design was based on the heptad repeat sequence of an a-helical coiled coil (O'Neil 
and DeGrado, 1990 and Lovejoy et al., 1993).  The coil-Ser a-helical bundle has an 
antiparellel packing arrangement, in which each a-helix is made of four heptad repeats. 
The structure of coil-Ser served as a template for designing monomeric 3-helix bundles 
with up and down topology (Bryson et al., 1998 and Walsh et al., 1999). In these designs, 
the helices were shortened to a length of three heptads, and interhelical electrostatic 
interactions (Lumb & Kim, 1995) were used to define a unique topology. To simplify the 
study of the domain swapping, the helices were further shortened to a length of two 
heptads, resulting in a three helix bundle with 14 residues per helix. The helices were 
connected by loops to provide two different topologies of helix bundles: (1) up-down-up 
topology (Mon1) and (2) up-down-down topology (Mon2) (Ogihara et al., 2001) (Figure 
1.7). Loop deletion is a common mechanism for 3D domain swapping (Green et al., 1995, 
Dickason and Huston, 1996 and Pei et al., 1997). Therefore, deleting the second loop from 
the helix bundle would lead to an open monomer that could form a domain-swapped 
dimer. 
Mon1 was crystallized and its structure was determined. The structure revealed 
that Mon1 formed a domain-swapped dimer. Residues 1a-14a, 19a-48a (monomer A), 1b-
13b, 19b-48b (monomer B) are a-helical. The hairpin loop residues 15a-18a and 14b-18b 
form turns connecting domain I and domain II of each monomer (Ogihara et al., 2001) 
(Figure 1.7).   




Figure 1.7.  Reproduced from Ogihara et al., 2001. (A) Design of Mon1 (up-down-up 









scattering, CD spectroscopy and Fourier transform-IR spectroscopy because of the 
difficulties in crystallization. At both acidic and neutral pH, electron micrographs shows 
that Mon2 form long fibrous aggregates. The fibrils are 40-70 nm in width and up to 
several thousand nm in length. These fibrils are composed of several protofibrils, 
corresponding approximately to the thickness of one to three triple stranded a-helical 
bundles. The structure of Mon2 oligomer is not known, but all the results strongly 
indicates that 3D domain swapping is the mechanism for Mon2 oligomer formation 
(Ogihara et al., 2001) (Figure 1.7).   
 
 Human cystatin C dimerizes through 3D domain swapping 
Human cystatin C is a cysteine protease inhibitor belong to the papain and legumain 
families (Turk and Bode, 1991 and Grubb, 2000). Three types of cystatins are present in 
higher animals: type 1, without signal peptides (cystatins A and B); the secretory type 2 
cystatins (C, D, E, F, S, SN, SA) and the multi-domain type 3 cystatins (high and low 
molecular weight kininogens). Human cystatin C (HCC) is composed of 120 amino acids 
(Grubb, 2000) and contains, as do other type 2 cystatins, four Cys residues forming two 
characteristic disulfides (Janowski et al., 2001). Wild type HCC forms part of the amyloid 
deposits in brain arteries of elderly patients suffering from cerebral amyloid angiopathy 
(Grubb, 2000). In hereditary cystatin C amyloid angiopathy (HCCAA), occurring in the 
Icelandic population, a natural variant of HCC (Leu68Gln) forms massive amyloid 
deposits in brain arteries of young adults leading to lethal cerebral hemorrhage (Olafsson 
& Grubb, 2000).  
Crystallographic and NMR studies of three cysteine protease inhibitor, chicken
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cystatin (Bode et al., 1988, Dieckmann et al., 1993 and Engh et al., 1993 ), cystatin B in 
complex with papain (Stubbs et al., 1990 ) and cystatin A (Martin et al., 1995), provide 
the information about the overall fold of cysteine protease inhibitor. The canonical 
features of this fold includes the long a1 helix running across a large five-stranded 
antiparellel b-sheet. The antiparellel b-sheet has the following connectivity: (N)-b1-a1-
b2-L1-b3-(AS)-b4-L2-b5-(C) (Figure 1.8A), where AS is a broad ‘appending structure’ 
and positioned on the opposite site of the b-sheet relative to the N-terminus and loops L1 
and L2 (Janowski et al., 2001). 
Three regions of cystatin are important in interaction with cysteine protease. These 
regions include the N-terminal segment and loops L1 and L2 (Janowski et al., 2001). The 
cubic crystal form of HCC  was obatained from a solution containing monermeric protein. 
The crystal structure revealed that HCC forms a dimer with two identical domains 
contributed by both molecules. The molecules are formed by two fold symmetry. 
Furthermore, the HCC dimer is formed via 3D domain swapping (Janowski et al., 2001). 
The domain-swapped domains consist of an a-helix and two b-strands, b1 and b2 (Figure 
1.8B).  
Each domain of the HCC is composed of the general fold of the chicken cystatin 
(Bode et al., 1988). The N-terminal subdomain consists of a short b1 strand followed by 
the a1 helix. After forming a loop at residue Asn 39, the chain forms the long b2 strand. 
The b-strands, b3-b5, form the b-subdomain through the linker region bL (former L1). 
The HCC dimer forms an open interface through the b-sheet interaction in the bL region, 
in addition to the closed interface, a-b interface (Figure 1.8B). The open interface is 
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  Figure 1.8. Reproduced from  Janowski et al., 2000.A. The fold of chicken cystatin. B. 
Domain swapped dimer HCC in two different view angles. The red dot is the site of the 





composed of an unusually long antiparellel b-sheet formed by two copies of strand (b2-
bL-b3), which cross from one domain to another and are involved in as many as 34 main 
chain hydrogen bonds. 
The bL strands corresponds to the L1 inhibitory loop in the canonical cystatin fold. 
The disappearance of the loop L1 in the HCC dimer structure and the consequent 
disruption of the HCC functional element agree with the observation that the HCC dimer 
has absolutely no inhibitory effect on C1 type proteases (Abrahamson and Grubb, 1994). 
However, loop 39-41, which connects helix a1 with strand b2 and contains Asn 39 that is 
crucial for HCC inhibition of mammalian legumain, is not affected by dimerization. This 
agrees with the observation that HCC dimer is an active inhibitor of porcine legumain like 
the monomeric protein (Alvarez-Fernandez et al., 1999). Leu 68 is located in the central 
strand (b3) of the b-sheet, on its concave face and covered by helix a1 (Figure 1.8B). In 
the hydrophobic core of the protein, this residue occupies a pocket formed by the 
surrounding residues of the b-sheet and the hydrophobic face of the helix. Leu 68 is 
surrounded by Val 66 and Phe 99 of the same monomer, as well as Leu 27, Val 31, Tyr 34 
(in the a-helix) and Ala 46 (strand b2) of the complementary monomer. These residues 
make an enclosed hydrophobic environment around Leu 68. Replacement of the Leu side 
chain by the longer Gln side chain, as in the naturally occurring L68Q variant, would not 
only form tight contacts but would also place the mutated hydrophilic chain in a 
hydrophobic environment. This would most probably destabilize the hydrophobic pocket. 
The hydrophilic side chain exerts a repulsive force on the a-helix, together with the strand 
b2, from the compact molecular core and forces the molecule to unfold into an open 
monomer. NMR spectroscopy shows that there is an increase in the dynamic nature of the 
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L68Q mutant compared to wild type HCC (Ekiel et al., 1997 and Gerhartz et al., 1998). It 
is conceivable that the refolded dimer recreates the topology of monomeric HCC, whereby 
the destabilizing effect would be similar in both cases. However, the dimeric structure 
may be more resistant to destruction because of the extra stabilizing contribution from the 
open interface, b-sheet interaction in the bL region (Janowski et al., 200). 
Human cystatin C dimers swap only the N-terminal domain (Janowski et al., 200). 
Higher oligomer may also arise by domain swapping of the N-terminal domain of the 
HCC which forms part of the amyloid deposits in brain arteries of elderly patients 
suffering from cerebral amyloid angiopathy (Figure 1.9).  
 
Hinge loop role in 3D domain swapping 
A hinge loop has the intrinsic flexibility to adopt different conformations in the monomer 
and in the domain-swapped oligomer. The flexibility is evident in RNase A, BS-RNase 
and human pancreatic ribonuclease (hRNase) chimera. RNase A and BS-RNase show 80% 
sequence identity, and BS-RNase and hRNase chimera share the common hinge loop. All 
three of these proteins swap the N-terminal helix. However, the relative orientations of the 
subunits in their dimers are different and resulting in different conformations for the three 
hinge loops (Mazzarella et al., 1993, Liu et al., 1998 and Canals et al., 2001).  
Great flexibility is also exhibited in the C-terminal hinge loop of RNase A: the C-
terminal strand of RNase A is swapped in both the C-terminal swapped dimer and the 
cyclic C-terminal swapped trimer of RNase A. The same hinge loop adopts different 
conformation in monomer, dimer and trimer.  
Hinge loops show a variety of secondary structures in domain-swapped proteins.
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 Figure 1.9. Reproduced from Janowski et al., 2000. In this diagram, the cystatin fold is 
represented by a a-helix (cylinder) running across the concave face the b-sheet (stripes). 
In a screw operation, new components are added by rotation followed by a translation 









Some hinge loops are coils, some are b-strand and others are a-helix. In the RNase, the N- 
terminal swapped dimer shows that one hinge loop is a coil and the other one is an a-helix 
(Mazzarella et al., 1993 and Canals et al., 2001). A common feature is that when the hinge 
loop forms an a-helix or a b-strand, the oligomer is favored over the monomer. These 
proteins usually exist as dimers in vivo or have dimeric forms more stable than the 
monomeric forms (Liu et al., 1998). Other domain-swapped oligomers are more stable 
than their monomers are those for which hinge loop is shortened by a deletion, then the 
closed monomer is no longer possible (Bennett et al., 1995).  
 
PROTEIN X-RAY CRYSTALLOGRAPHY 
 
In 1947 Perutz, along with Kendrew, founded the Medical Research Council Unit for 
Molecular Biology at Cambridge. There, the two men continued their investigation of 
hemoproteins, with Kendrew trying to determine the molecular structure of myoglobin 
(muscular hemoglobin) and Perutz concentrating on the hemoglobin molecule itself. In 
1960 Perutz showed that the hemoglobin molecule is composed of four separate 
polypeptide chains that form a tetrameric structure, with four heme groups near the 
molecule's surface. However, he did not determine the first three-dimensional structure of 
a protein molecule. The first three-dimensional structure was determined by John 
Kendrew.  By 1957 Kendrew obtained an electron density map at 6Å resolution which 
allowed him to build a rough molecular model of myoglobin, and two years later he 
extended the resolution to 2.0Å, allowing him to build an atomic model. For their work, 
Perutz and Kendrew were awarded the Nobel Prize for Chemistry in 1962. This 
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pioneering work led to steady increase in the number of proteins structure determined by 
using X-ray diffraction. The numbers of protein structures determined by X-ray 
crystallography is approximately 20000 as of 2004. 
 
Protein crystallization  
Obtaining a suitable single crystal is the least understood step in the X-ray structural 
analysis of a protein. Protein crystallization is mainly a trial and error process. The 
crystallization of a protein involves four important steps. 
1. The purity of the protein is important.  
2. The protein should be dissolved in a suitable solvent. The solubility of proteins in 
water depends on properties such as temperature, pH, and the presence of other 
solution components as well as amino acid composition.  
3. The concentration of a protein solution is brought above its solubility limit, until 
the solution becomes supersaturated.  
4. When a protein solution is brought to the supersaturated point, the protein begins 
to aggregate and forms nuclei. Once nuclei have formed, actual grystal growth can 
begin. 
 
Crystal systems and symmetry  
The key to unlocking the structure of crystals is finding the symmetry of the crystal's unit 
cell in the X-ray pattern. A unit cell is a set combination of atoms or molecules which 
forms a repeating pattern throughout the crystal. Like bricks in a wall the entire structure 
can be created by simple translations of the fundamental unit. Unit cells exist in three 
dimensions and thus have three sides (a, b and c) with three angles between each of the 
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combinations of two sides (a between b and c, b between a and c and g between a and b). 
Based on the relations between a, b, c, a, b and g, all crystals are placed into one of seven 
crystal systems. These systems are further divided into 32 crystal classes based on the 
symmetry point groups which they exhibit. These point groups defined by their 
operations: inversion through a point, rotation about an axis, reflection through a mirror 
plane and inversion through a point after rotation about an axis. The 32 crystal classes are 
in turn further broken into 230 space groups, based on symmetries derived from one of 
two basic translational operations: screw axes and glide planes. Since proteins are 
asymmetric objects and occur only in the L-form they cannot involved in symmetry 
element requiring inversion centers, mirrors or glide planes. This limits the possible space 
groups to 65 out of the 230 mathematically possible space groups.  
 
X-ray diffraction and Bragg's Law  
Protein crystallography is a widespread technique for the determination of the three-
dimensional structure of protein molecules. It is based on the study of X-ray diffraction 
patterns by crystals of a protein. Atoms diffract X-rays in a pattern which is dependent on 
their location in three-dimensional space. To detect diffracted X-rays with high sensitivity, 
it is essential that many atoms contribute to the diffraction pattern obtained. This means 
that the molecule under investigation must be present in the ordered three-dimensional 
array within the crystal so that many equivalent atoms in different molecules contribute to 
the diffraction pattern.  
The Bragg equation relates to the spacing between crystal planes, d, to the 
particular Bragg angle, ?, at which reflections from these planes are observed. Bragg’s law 
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indicates that diffraction is only observed when a set of planes makes a very specific angle 
with the incoming X-ray beam. This angle depends on the inter-plane spacing d. Bragg's 
Law refers to the simple equation: nl = 2d sin ?.  
 
Ewald construction 
A most useful mean to understand the occurrence of diffraction spots is the Ewald 
construction. We draw a sphere of radius 1/?, in the center of which we imagine the real 
crystal. The origin of the reciprocal lattice lies in the transmitted beam, at the edge of the 
Ewald sphere. Whenever the end point of scattering vectors, within length 1/d, fall on the 
sphere, Brgg’s law is satisfied and reflection occurs. Furthermore, the end point of 
scattering vectors must be reciprocal lattice points (Figure 1.10). Crystal lattice planes for 
which the reciprocal lattice points do not lie on the sphere and thus are not in reflecting 
position can be brought to refection by rotating the crystal.  
 
The structure factor  
The structure factor can be calculated as  
 








)](2exp[)( p                                                                         (1.1) 
 
fj  is the scattering factor of atom j. x, y, z are the fractional coordinates of each atom in the 






Figure 1.10. Ewald construction. Scattering vectors has length 1/d (red) and the sphere of 
radius 1/? (blue). Whenever scattering vectors have their end points on the sphere, Brgg’s 












Fourier transform and phase problem 
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¦ F(h k l)¦  is the structure factor amplitude of reflection (h k l)  and a (h k l) is the phase angle. 
x, y, z are the coordinates to what in the unit cell (1.2). From I(h k l), amplitude ¦ F(h k l)¦  
can be calculated but no information is available on the phase angle. This is called phase 
problem. In principle, four techniques exist for solving the phase problem in protein X-ray 
crystallography. 
If we already have the coordinates of a similar protein we can try to solve the 
structure using a process called Molecular Replacement which involves taking this model 
and rotating and translating it into our new crystal system until we get a good match to our 
experimental data. If we are successful then we can calculate the amplitudes and phases 
from this solution which can then be combined with our data to produce an electron 
density map.  
If we have no starting model, then we can use Isomorphous Replacement methods 
whereby one or more heavy atoms are introduced into specific sites within the unit cell 
without perturbing the crystal lattice. This is another trial-and-error procedure and often it 
is not apparent whether it has worked until more X-ray data have been collected. Heavy 
atoms are electron dense and give rise to measurable differences in the intensities of the 
spots in the diffraction pattern. By measuring these differences for each reflection, it is 
 34 
possible to derive some estimate of the phase angle using vector summation methods. In 
practice data from one or more heavy atom derivatives is required to get good enough 
phases - hence Multiple Isomorphous Replacement (MIR). Again we use a Fourier 
transform to calculate a map.  
In some cases we can make use of the anomalous scattering behavior of certain 
atoms at or near their X-ray absorption edges to gain useful phase information. Many of 
the atoms used in isomorphous replacement are also useful in this respect. This additional 
information can enhance the structure solution. Multiwavelength Anomalous Dispersion 
(MAD) is an elegant and often very effective method that relies entirely on the 
measurement of the anomalous differences produced by one or more anomalously 
scattering atoms in the crystal. In practice three or more consecutive data sets are recorded 
from the same crystal at different wavelengths around the X-ray absorption edge of the 
anomalous scatterer. As this method requires a tuneable X-ray source, it can only be 
performed at a synchrotron. The resultant phase information can often produce very high 
quality electron density maps, thereby simplifying the subsequent interpretation. Selenium 
is a particularly good anomalous scatterer and it can be incorporated into proteins by over-
expressing them in strains of E. coli that are auxotrophic for methionine. The host cells are 
then grown on minimal media supplemented with amino acids using selenomethionine in 
place of methionine. 
Direct Methods are commonly used by crystallographers to determine relatively 
small crystal structures. However, traditional approaches do not appear to be extensible to 
larger structures. Hauptman and Jerome Karle won a Nobel prize in 1985 for their work in 
the late 1940s and early 1950s on the direct method, a mathematical approach that makes 




This is the process where the electron density map is interpreted in terms of a set of 
atomic coordinates. This is more straightforward in the molecular replacement case 
because we already have a coordinate set to work with. In the case of isomorphous 
replacement we simply have the map. The normal procedure is to fit a protein backbone 
first then if the resolution permits, we insert the sequence. The amount of detail that is 
visible is dependent on the resolution and the quality of the phases. Often regions of high 
flexibility are not visible at all due to static disorder, where the structure varies from one 
molecule to the next within the crystal.  
 
Refinement 
Once we have a preliminary model we can refine it against our data. This will have the 
effect of improving the phases which results in clearer maps and therefore better models. 
We would typically go round this cycle several times until we get little or no further 
improvements. At this stage we would expect a crystallographic R-factor of below 25%. 
This is a measure of the agreement between the model and the data – the lower the value 
the better the model. Nevertheless, the final model must make chemical sense and there 






AIM AND SCOPE OF THE THESIS 
 
The fungal immunomodulatory protein from the edible golden needle mushroom 
(Flammulina velutipes), designated Fve, is a single polypeptide consisting of 114 amino-
acid residues. It is believed to trigger the mitogenic proliferation of T lymphocytes and 
Th1 cytokine production. Fve forms a homodimer in nature. On the other hand, rhodocetin 
is purified from the crude venom of the Malayan pit viper, Calloselasma rhodostoma, 
functions as a novel platelet aggregation inhibitor induced by collagen. The molecule, 
rhodocetin has been shown to have activity only when present as a dimer. It is a unique 
heterodimer consisting of a and b subunits of 133 and 129 residues respectively. 
Structural studies of these proteins are expected to contribute significantly towards 
understanding structure-function relationships of the proteins. Furthermore, both dimers 
were believed to be formed by a mechanism called 3D domain swapping. Therefore, 
functional and structural studies of these proteins were initiated to better understand the 
mechanisms. Explicitly, the objectives of the study were: 
 
1. To crystallize the protein. 
2. To collect native and derivative data. 
3. Find appropriate methods to solve the structures. 
4. Build the models.  
5. Use the structural information to study the structure-function relationships and 























For centuries, the higher fungi, Basidiomyceta - more popularly, mushrooms - have 
figured strongly in traditional medicine, particularly in the Chinese and Japanese cultures, 
to promote good health and vitality and to enhance body's adaptive capabilities. But 
though their culinary and nutritional merits are widely accepted, the utility in modern 
medicine of mushrooms and their component biomolecules, is only now being 
appreciated. In just the last few years, the literature has burgeoned with reports of proteins, 
glycans and small molecules isolated from these fungi, possessing a variety of activities: 
immunopotentiating, anti-tumor, genoprotective, cholesterol-lowering, hypoglycemia-
inducing and appetite-suppressing, to name a few (Wasser et al., 1999). Ancient wisdom 
is vindicated since mushrooms are a rich source of pharmacologically important 
biomolecules, promising much both as tools to study biological processes and as leads for 
the development of therapeutics.  
The golden needle mushroom, Flammulina velutipes, and extracts thereof, possess 
immunomodulatory, anti-tumor, antiviral and cholesterol-lowering activities (Wasser et 
al., 1999; Otagiri et al., 1983; Ikekawa et al., 1995; Wang et al., 2000; Fukushima et al., 
2001). A major fruiting body protein, designated Fve or FIP-fve, was isolated and very 
likely plays a significant role in the mushroom’s immunomodulating effects (Ko et al., 
1995). It stimulates mitogenesis of human peripheral lymphocytes, suppresses systemic 
anaphylaxis reactions and local swelling of mouse foot pads, and enhances the 
transcription of interleukin-2 (IL-2), interferon-g (IFN-g) (Ko et al., 1995) and tumor 
necrosis factor-a (TNF-a;  Seow et al., 2003).  In addition, it hemagglutinates human red 
blood cells (Ko et al., 1995). Several simple sugars tested did not inhibit Fve-induced 
hemagglutination (Ko et al., 1995). Fve is a non-covalently linked homodimer (Seow et 
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al., 2003), each subunit 114 amino acids in length. It contains no Cys, Met or His residues 
and its N-terminal Ser residues are acetylated (Ko et al., 1995). It shows sequence 
similarity only to other mushroom proteins with similar functional characteristics: LZ-8 
(Ganoderma lucidum, Kino et al., 1989), Gts (Ganoderma tsugae, Lin et al., 1997), Vvo 
(Volvariella volvacea, Hsu et al., 1997) and Vvl (Volvariella volvacea, She et al., 1998). 
All these proteins form the novel Fungal Immunomodulatory Protein (FIP) family (Ko et 
al., 1995) (See appendix).  
To better understand structure-function relationships in this family of proteins, we 
determined its three-dimensional structure.   
 
MATERIALS AND METHODS 
 
Protein purification 
Fve was purified from Flammulina velutipes as previously described (Ko et al., 1995) 
with some modifications (Seow et al., 2003). Essentially, proteins from a 5% acetic acid, 
50 mM 2-mercaptoethanol extract of fruiting bodies were precipitated with 95% 
ammonium sulfate. The precipitate was dialyzed against 10 mM Tris-HCl, pH 8.5. The 
dialysate was applied to a Q-Sepharose FF column equilibrated with 10 mM Tris-HCl, pH 
8.5. The unbound proteins were then loaded on an SP Sepharose FF column equilibrated 
with 10 mM sodium acetate pH 5.0. Fractionation with a 0 – 0.5 M NaCl gradient yielded 
pure Fve. All steps of the purification were performed at 4° C and hemagglutination 
assays were used to follow the purification. The purity of Fve was assessed by SDS-
PAGE and electrospray ionization mass spectrometry. 
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Protein crystallization and data collection 
Well-diffracting Fve crystals were grown by vapor diffusion from hanging drops at 2.5% 
PEG 400, 2.0 M (NH4)2SO4, 0.1 M Tris-base, pH 8.5 at 21°C over 3-5 days (Seow et al., 
2003). Heavy atom derivatives were prepared by soaking the crystals in mother liquor 
containing 25% glycerol and 1 M NaBr for 1 min, after which the crystals were flash-
frozen at 100 K. SAD data from a derivatized crystal were collected at the National 
Synchrotron Light Source (NSLS) beam line X12C at one wavelength (0.92020 Å) around 
the Br absorption edge. The crystal diffracted to 1.7 Å. It belonged to the tetragonal space 
group P43212 and had unit cell dimensions a = b = 97.12, c = 61.41 Å and a = b = g = 
90.0º. This gave a Matthew’s co-efficient (Matthews et al., 1968) of 2.9 Å3.Da-1 and a 
solvent content of 56.5%, with one molecule (dimer) per asymmetric unit. The SAD data 
were processed and scaled using DENZO and SCALEPACK from the HKL2000 suite of 
programs (Otwinowski et al., 1997).  
 
Structure solution and refinement 
All of the bromine heavy atom positions were located and refined by the program SOLVE 
(Terwilliger et al., 1999) at 1.7 Å and a solvent flattened map was calculated using 
RESOLVE (Terwilliger et al., 2001). The resulting electron density map revealed 
secondary structure elements and side chains (Figure 2.1). The phases obtained from 
RESOLVE were directly used in ARP/wARP (Morris et al., 2002) for automated main 
chain tracing, resulted in the building of four continuous fragments that contained 97% of 
the model. The rest of the model and side chains were fitted manually using XtalView 





Figure 2.1. Portion of experimental electron density from RESOLVE contoured for 2s 











                    
 
Fig 2.2. Overall structure of the Fve dimer solved by SAD of an NaBr-soaked crystal. 
Each monomer consists of an FNIII-like domain with an N-terminal a-helix and b-strand. 
The a-helices (HA and HB) interact via hydrophobic interactions while the b-strands (SA 
and SB) form a b-sheet. The FNIII domain consists of a sandwich of two sheets, I and II, 
formed by b-strands E-B-A and G-F-C-C', respectively (labels on monomer A). The Br 












(Murshudov et al., 1999) using data in the resolution range of 30.02 Å - 1.7 Å and water 
molecules were identified using ARP/WARP later in the refinement. The data collection 
and refinement statistics are shown in Table 2.1. Poor electron density in corresponding 
regions necessitated the omission of the side chain of Thr 114 of chain A and residues Lys 
113 and Thr 114 of chain B from the model. The quality of the final model was verified 
with PROCHECK (Laskowski et al., 1993). Of note is Lys 14 in both A and B chains, 
which, though fitting very well in the 2fo-fc map, falls in the disallowed region in the 
Ramachandran plot (Figure 2.3). Interestingly, Lys14 participates in both the N-terminal 
helix (Ala 2 to Lys 14) by the formation of a H-bond between its backbone N atom and 
the C=O group of Ala10, as well as the ensuing b-sheet (Lys 14 to Asp 19) by a H-bond 
between its C=O group and the backbone N atom of Tyr20 of the other monomer (Figure 
2.4). It is likely that both these H-bonds introduce strain in the peptide backbone of Lys14 
causing a departure from the allowed phi/psi angles for both a-helices and b-sheets. The 
atomic co-ordinates and structure factors have been deposited in the Protein Data Bank 
(Berman et al., 2000) (PDB) as entry 1OSY. MolScript was used for molecular drawing. 
 
RESULTS AND DISCUSSION 
 
Overall fold  
The Fve dimer is a dumb-bell shaped molecule, with approximate dimensions of 80 Å × 
40 Å × 32 Å (Figure 2.1). The conformations of the two monomers (A and B) are nearly 
identical as they superimpose almost perfectly: the RMSD between their first 112 residues 
is 0.29 Å (Ca atoms alone) and 0.87 Å (all atoms). The N-terminal Ser residues are
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Table 2.1. Data collection, phasing and refinement statistics. 
 
Data collection 
Space group     P43212 
Unit cell parameters (Å, °)    a = b = 97.12, c = 61.41, a = b = g = 90.0 
Resolution range (Å)                    30.0 - 1.7 
Number of observed reflections          464964  
Number of unique reflections       32880 (3249) 
Redundancy     14.1 
Completeness (%)                         100 (100) 
*Rmerge (%; all reflections)                   0.045 (0.187) 
Matthews co-efficient (Å3.Da-1)  2.8  
Solvent content (%)    56.4 
Number of molecules per asymmetric unit 2 








Number of protein atoms                     1788 
Number of bromine atoms                  16 
Number of water molecules                 136 
 
R-factor                                        0.182 
Rfree (test set of 5%)                  0.210 
Data cutoff in s units            none  
RMS bond length                         0.010 
RMS bond angle                        1.466 
RMS chiral                                 0.231 
 
 
Values for parameters in the highest resolution shell, 1.76 – 1.70 Å are parenthesized and 














Figure 2.3. In Fve, Lys14 in both A and B chains falls in the disallowed region of the 



















Figure 2.4. The departure from allowed phi-psi angles is likely due to the strain imposed 
when the backbone N and C=O of Lys14 H-bonds with the C=O of Ala10 and the 










blocked by acetyl groups, the density for which is clearly observed in both subunits. Each 
subunit comprises of a pair of N-terminal secondary structural elements, an a-helix 
followed by a b-strand, linked to a domain consisting almost exclusively of b-sheets 
adopting an Ig-like fold (Figure 2.1). The N-terminal a-helices in both subunits 
(designated HA and HB) span 13 residues from Ala 2 to Lys 14, and the b-strands (SA and 
SB), which run antiparallel to each other form a two-stranded b-sheet, from Lys 14 to Tyr 
20. These secondary structure elements play a critical role in dimerization, and are 
important for the activity of the protein (see below). The rest of the subunit (residues Tyr 
20 to Thr 114), folds into an Ig-like domain (Figure 2.1) consisting of seven major 
antiparallel b-strands arranged into two sheets of three (b-strands A, B and E) and four 
(b-strands C, C’, F and G) packed against each other (for nomenclature of b-strands, see 
below). The two sheets are rotated with respect to each other by an angle of ~41°. b-strand 
A stretches from Pro22 - Gly25, B from Ser31 - Thr37, C from Tyr47 - Val52, C’ from 
Gly55 - Val60, E from Gly71 - Ile74, F from Thr90 - Val95 and G from Glu104 - Glu110. 
The strands forming the two main b-sheets are connected by loops. The A-B, C-C’ and F-
G hairpins are each connected by type II b-turns:  Gly27-Thr-Pro-Ser30, Val53-Asn-Gly-
Ser56 and Thr100-Gly-Asn-Ser103, respectively. A type I b-turn (Thr67-Pro-Ser-Gly70) 
is found in the C’-E inter-sheet crossover loop, while two b-turns, a type I (Ala86-Asp-
Thr-Lys89) and a type II (Asn80-Lys-Gly-Tyr83), are found in the E-F crossover loop, in 
addition to a 310 helical turn (Phe76 – Tyr79) and a short b-strand (Gly84 - Val85). 
Structural comparison of the Fve monomer against all structures in the PDB 
database using the program Dali (Holm et al., 1993) (which maximizes a geometrical 
similarity score calculated from intramolecular distances in the common core) revealed 
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140 significant hits with a Z-score > 2.0. The top 14 hits (Z-score > 5.0) were all Ig-like b-
sandwich domains belonging to either FNIII-type or Ig-like SCOP (Murzin et al., 1995) 
superfamilies (C1 and V sets) (data not shown). [In SCOP (Structural Classification of 
Proteins) (Murzin et al., 1995), proteins that have low sequence identities, but whose 
structural and functional features suggest a probable common evolutionary origin are 
placed together in superfamilies]. Structural alignment of these 14 domains with Fve using 
the program Topp (Lu, 1996) indicated that Fve had the highest 3D structural similarity 
(i.e., lowest topology diversity) to domains with the FNIII-type fold.  
 
Topology of FNIII fold in Fve 
A more rigorous examination of the b-strand arrangement in the Ig-like domain of Fve 
reveals some interesting features. As mentioned earlier, the domain consists of a sandwich 
of two b-sheets possessing three (A, B and E) and four (C, C’, F and G) antiparallel 
b-strands, respectively (Figure 2.1). This arrangement is characteristic of the strand-
switched type (s-type; sheet I: E-B-A, sheet II G-F-C-C’) topology of Ig domains (Figure 
2.5A; see [Bork et al., 1994] for classification), and is the hallmark of the FNIII domain. 
Strands B, C, E and F form the common core of the generic Ig-like fold (Bork et al., 
1994). The polypeptide chain segment between strands C and E has to change direction by 
at least 180° and cross over to the other sheet; this is achieved via the C’ strand in domains 
with s-type topology (Figure 2.5A). It has been shown that, within the Ig-like fold, there is 
a strong correlation between the number of residues between strands C and E, and the 
topological subtype (Bork et al., 1994). Ig-like folds with s-type topology 
characteristically contain seven to ten residues between a reference point C* (the residue 
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at the beginning of strand C’ in the s-type topology (Bork et al., 1994)) and the beginning 
of the E strand.  Interestingly, in Fve, there are 17 residues between C* (Val53) and the 
beginning of strand E (Gly71), much more reminiscent of domains with h-type topology 
(Figure 2.5C) wherein sheet crossover from common core strands C to E occurs via a long 
kinked strand C’/D (Bork et al., 1994). In the h-type topology, the N-terminal residues of 
this segment form hydrogen bonds with strand C (sheet II) whereas the C-terminal 
residues belong to sheet I (Figure 2.5C). In Fve, the segment from Gly55 to Pro68 bears a 
striking resemblance to h-type topology, strand C’/D (Figure 2.5B). It consists of two 
distinct segments demarcated by a kink at Asn63. The N-terminal segment corresponds to 
the canonical C’ strand in s-type or h-type topology. However, unlike in h-type topology, 
the C-terminal segment traverses alongside strand E in the plane of sheet I, but not quite 
close enough to form hydrogen bonds with strand E in a manner required to participate in 
the formation of the sheet (the exception being the N atom of Thr67 H-bonding with the 
C=O of Gly71). This non-participation may be compounded by the fact that asparagine (in 
position 63) does not have a high propensity to participate in b-sheet formation (Chou et 
al., 1978). Hence, it appears that while Fve, with strict consideration of its seven b-
stranded fold, has s-type topology, in reality it has a pseudo-h-type topology, wherein 
there is a “pseudo-D” polypeptide segment in an equivalent 3Dimensional position to h-
type strand D, enabling strand C to make the crossover to strand E, but which is not close 
enough to strand E to facilitate H-bonding with it (Figure 2.5B). There are a few other 
domains that are classified under s-type topology and have extended C*-E regions (Bork 
et al., 1994). Among these, domain 1 of the human growth hormone receptor (PDB entry 
3hhr) has the closest similarity to the pseudo-h-type fold of Fve.  However, it is still
 50 
 
Figure 2.5. S-type topology (A), as in FNfn10, is adopted when 7 b-strands form a 
sandwich of 2 sheets. While the Ig-like fold in Fve resembles S-type topology in that it 
has 7 strands forming 2 sheets, it has additional segment (shown in yellow) that resembles 
strand D (yellow) in H-type topology (C). The pseudo-D strand is shown with a dashed 
arrow (B). The four common core b-strands, B, C, E and F are shown in red. 
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clearly s-type, since the polypeptide segment corresponding to the D strand is not in the 
plane of sheet I and is at right angles to it.  
 
Determinants of the Ig-like fold 
 Common hydrophobic core. It is important to note that although Fve possesses a FNIII-
type fold, it has no significant sequence similarity to any Ig-like fold-containing protein, 
and therefore a common evolutionary origin appears unlikely. The structural similarity 
perhaps arises from the chemistry of proteins favoring certain packing arrangements and 
chain topologies. A significant amount of work has been done to delineate the structural 
determinants of the Ig-like fold (see Bork et al., 1994, Clarke et al., 1999, Hamill et al., 
2000 and Cota et al., 2001 and references therein). The Ig-like fold is one of ten proposed 
“superfolds” (Orengo et al., 1994 and Salem et al., 1999) – protein folds that are adopted 
by unrelated sequences and appear frequently in the database of known structures. The Ig-
like fold is adopted by different superfamilies such as the Igs (Williams et al., 1988 and 
Chothia et al., 1998), FNIII modules (Baron et al., 1991 and Doolittle et al., 1993) and 
other more diverse families (Bork et al., 1994). Clarke et al., 1999 performed a structural 
and folding comparison of six Ig-like proteins with no significant sequence similarity and 
identified two trends that are independent of residue identity in the core: a clear 
correlation between domain stability and rate of folding; and a correlation between 
domain stability and the population of folding intermediates. The most likely explanation 
proposed was that the main determinants of the folding pathway are found in the common 
elements that define the fold, i.e., a common folding nucleus. The folding nucleus of an 
FNIII-type domain is composed of hydrophobic residues in the central strands (B, C, E 
and F) of the b-sandwich that form a large core of interactions in the transition state (Cota 
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et al., 2001). Although Fve has no sequence similarity to other FNIII-type domains, it 
does have a significant hydrophobic core (Figure 2.6) comprised of residues with <10% 
relative surface exposure: Ile33, Leu36, Val51 and Phe38 (B strand); Tyr47, Tyr49 and 
Val52 (C strand); Gly71, Gly72 and Ile74 (E strand); Ile91, Val93 and Val95 (strand F).  
 
Position of proline residues. Important for the elaboration of the fold, and the common 
hydrophobic core, is the presence of proline residues in FNIII-type domains, that are 
found mainly in loop regions or at the start or end of b-strands (Steward et al., 2002). Fve 
also has several prolines in these regions (Figure 2.7). Pro22 is located at the start of 
strand A and appears to hold a key position in the domain swapping mechanism of 
dimerization (see discussion below). Pro29 is part of the type II b-turn linking strands A 
and B, while Pro39 is at the end of strand B, introducing a bend in the polypeptide chain 
facilitating its turn into strand C. Pro68 is within the type I b-turn within the C’-E inter-
sheet crossover loop, while Pro98 is in the loop between the F and G strands.  
 
Absence of tyrosine corner. Another structural feature of the FNIII domain (and Ig-like 
domains in general) is the “tyrosine corner” motif (Hemmingsen et al., 1994), that is 
found in >90% of (even sequence-unrelated) FNIII and Ig variable domains (Hamill et al., 
2000). It consists of a tyrosine, equivalent to residue Lys89 in Fve, residue in the F strand 
that forms an H-bond with the local protein backbone in the adjacent E-F loop, which 
crosses from one sheet to the other (Figure 2.8). The tyrosine corner thus acts as a 
structural restraint of this loop connecting the b-sheets. The high conservation of this 





Figure 2.6. Although Fve has no sequence similarity to other FNIII-type domains, it has 
the characteristic hydrophobic core required to nucleate folding in FNIII domains. The 
hydrophobic residues in the central strands (B, C, E and F) of the b-sandwich are Ile33, 
Leu36, Val51 and Phe38 (B strand); Tyr47, Tyr49 and Val52 (C strand); Gly71, Gly72 
and Ile74 (E strand); Ile91, Val93 and Val95 (strand F). Side-on (left) and face-on (right) 






         
                                  
Figure 2.7. Stereo view showing the presence of prolines in loop regions or at the start or 
end of b-strands is important for stability of the FNIII fold. Fve has several prolines in 
these regions. Importantly, Pro22, located at the start of strand A, appears to hold a key 

















Figure 2.8. Another characteristic of the FNIII fold is the tyrosine corner at the junction of 















backbone at this position (Hamill et al., 2000). Fve does not contain this tyrosine corner, 
but interestingly, this critical need is satisfied by the type I b-turn (Ala86-Asp-Thr-Lys89), 
with the backbone C=O of Ala86 forming an H-bond with the backbone N atom of Lys89 
(Figure 2.8).    
 
Structure-function relationships 
Carbohydrate recognition. Fve hemagglutinates human red blood cell, and has a 
stimulatory effect on human peripheral blood lymphocytes (hPBLs) (Ko et al., 1995). It 
also suppresses systemic anaphylaxis reaction and local swelling of mouse footpads, and 
enhances the transcription of IL-2, IFN-? (Ko et al., 1995) and TNF-a (Seow et al., 2003). 
The hemagglutinating activity of Fve was not inhibited by simple sugars such as D-
glucose, D-galactose, D-fucose, N-acetyl-D-galactosamine and D-lactose. However, the 
highly glycosylated porcine thyroglobulin was able to inhibit hemagglutination at a molar 
ratio of 1:4 (Fve: thyroglobulin), suggesting that Fve is a lectin with specificity for 
complex cell surface carbohydrates (unpublished observations).  Another family of lectins 
containing an Ig fold is the sialic acid binding Ig-like lectins (Siglecs). These proteins bind 
specifically to sialylated glycoconjugates, and their carbohydrate binding site and ligand-
binding determinants have been largely worked out (for example, see [Alphey et al., 
2003]). However, since the binding specificity of Fve has not yet been established, 
comparative studies between Fve and Siglecs, to delineate its carbohydrate binding site, 
are presently of limited utility.  
While there is no single template for recognition of carbohydrate-binding pockets 
it has been shown that certain amino acids show strong propensity to be in the 
 57 
carbohydrate binding site of proteins (Taroni et al., 2000). They are the residues with 
aromatic rings (Phe, Trp and Tyr) that can pack against the hydrophobic face of the sugar 
residues, and Arg, Asp and Glu residues, and can form bidentate interactions with adjacent 
hydroxyls on the sugar (Taroni et al., 2000). Searching for surface patches which have a 
local combination of these residue types provides a good first diagnostic for a sugar-
binding site (Taroni et al., 2000). Applying this system to Fve, we found two sets of 
patches that offer the potential to bind sugars. The first patch, consisting of residues 
Tyr11, Arg50, Asp 57, Phe94, Glu104, Glu105, Tyr 106 and Glu 110 is found on the same 
side of the dimer (Figure 2.9) The second patch, continuous with the first (and hence 
shares common residues), consists of Tyr 11, Trp24, Arg26, Asp87, Glu110 and Trp111. 
This pocket lies on opposite sides of the dimer (Figure 2.10). 
Preliminary data indicates that this second pocket may be involved in sugar-
binding as single-residue chemical modification of one of the two tryptophans, Trp24 and 
Trp111, (which are closely apposed to each other in the 3D structure) using 2,4-
dihydroxybenzyl bromide significantly diminished hemagglutination activity (unpublished 
observation). Further experiments, including site-directed mutagenesis, are underway to 
further delineate the carbohydrate binding site and the ligand for Fve. 
 
Dimerization by 3D domain swapping 
The structure of Fve clearly shows an exchange of the N-terminal a-helices, HA and HB, 
between the symmetry-related monomers suggesting that dimerization may occur by 3D 
swapping. 3D domain swapping is a mechanism for forming oligomeric proteins from 
their monomers (for reviews, see [Bennett et al., 1995 and Schlunegger et al., 1997]).
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Figure 2.9. Potential carbohydrate-binding sites in Fve. All residues with strong 
propensity to be in the carbohydrate-binding site of proteins (see text) are shown in red. 
The first patch (colored blue), consisting of Tyr11, Arg50, Asp 57, Phe94, Glu104, 








     
                                                      
Figure 2.10. Potential carbohydrate-binding sites in Fve. All residues with strong 
propensity to be in the carbohydrate-binding site of proteins (see text) are shown in red. 
The second patch (colored green), which is continuous with the first (and hence shares 
common residues), consists of Tyr 11, Trp24, Arg26, Asp87, Glu110 and Trp111. This 






Since the structure of the Fve monomer is not known, it falls into the category of 
candidate for domain swapping.  
There are three extended regions of subunit-subunit interactions within the dimer: 
(a) between HA and HB (residues 2 to 14), (b) between the N-terminal b-strands (SA and 
SB; residues 14 to 19), and (c) between the N-terminal helices and the FNIII modules of 
the opposite monomer. Helices HA and HB are amphipathic; each has hydrophobic 
residues Ala 2, Leu 5, Leu 9, Leu 12 and Val 13 located on one face. The side chains of 
the residues on the hydrophobic face of one helix pack well against those of the other 
helix enabling them to bind strongly to each other via hydrophobic interactions (Figure 
2.11). In Gts, another FIP with high sequence similarity to Fve, N-terminal residues 1-13 
were predicted to form an a-helix (Lin et al., 1997). Recombinant mutants of FIP-gts with 
residues 1-13 deleted were incapable of dimerization (Lin et al., 1997). Further, triple 
mutants with Leu 5, Phe 7 and Leu 9 deleted lost the amphipathic characteristics of its 
putative N-terminal helix, the ability to form dimers with itself and the wild-type FIP-gts, 
as well as its immunomodulatory activity (Lin et al., 1997). The structure of Fve 
corroborates these predictions and emphasizes the important functional role that the N-
terminal helix plays in dimerization and hence the functional lectin and 
immunomodulatory activity of FIPs. In addition to the hydrophobic interaction between 
helices HA and HB, the b-strands SA and SB run antiparallel to each other, forming a two-
stranded b-sheet, further strengthening the interaction between the monomers (Figure 
2.12). Both the inter-helix hydrophobic interaction and the hydrogen bonding between the 
sheets would not be found in the putative Fve monomer, but stabilize the dimer state. The 




Figure 2.11. Extensive hydrophobic interactions occur between the N-terminal a-helices 
(HA and HB). The hydrophobic residues Ala 2, Leu 5, Leu 9, Leu 12 and Val 13 located on 















Figure 2.12. The N-terminal b-strands (SA and SB) also form a b-sheet (hydrogen bonds 







monomers, by both direct hydrogen-bonding interactions (for example, between Thr 3 and 
Ser 4 of monomer A and Lys 45 and Tyr 106 of FNIII module B, respectively) as well as 
interactions via ordered water molecules (for example, between Ser 1 and Lys 14 of 
monomer A, and Glu 104 and Ile 108 of FNIII module B, respectively). In addition to 
these, hydrophobic interactions also exist, involving Phe 7, Ala 10 and Tyr 11 of 
monomer A and Tyr 106, Ile 107 and Ile 108 of FNIII module B (similar structural 
features occurring in another C-interface between swapped domain and the FNIII module 
A) (Figure 2.13).  In a domain-swapped dimer, interaction between the N-terminal helix 
and the FNIII module would likely be representative of the interaction in the putative 
monomer prior to dimerization. This interaction cannot be too strong, otherwise 
displacement of the helix by that of another monomer during dimerization would be 
energetically unfavorable. Monomer Fve is modeled based upon the crystallographic 
determined dimer (Figure 2.14). 
In the Fve monomer, the N-terminal a-helix (Ala2 to Lys14) is linked to the rest of 
the subunit by a hinge loop eight residues long, stretching from residue Lys15 to Pro22. 
(The average length of hinge loops in bona fide 3D domain-swapped proteins is nine 
residues). The distance of the C-a of Lys 15 to the C-a of Pro22 in the open monomer is 
22.1 Å, and hence satisfies the distance criterion for the length of the hinge loop (< 29.7 
Å) (Bennett et al., 1995). Finally, Pro22 can conceivably play a key role in the 3D domain 
swapping process as it occupies a critical position at the end of the hinge region (Figure 
2.7). Prolines are frequently found in the hinge region of domain-swapped proteins 
particularly at the point where the arm leaves the protomer (Bergdoll et al., 1997). 
Sequence alignment and site-directed mutagenesis confirm the importance of these 
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Figure 2.13.  Hydrophobic interactions involve Phe 7, Ala 10 and Tyr 11 of the swapped 

















conserved prolines (Bergdoll et al., 1997). Their occurrence at the hinge regions can be 
explained by the constraints they impose on polypeptide conformation and dynamics: 
rigidifying the main chain, favoring extended conformations of arms and prevention of 
interaction of the arms with the protomer core (Bergdoll et al., 1997). The strain 
introduced by prolines in the hinge region enables them to behave as “molecular springs” 
that release tension by adopting alternative conformations while respecting the overall 
structure of the protein (Rousseau et al., 2001).  
Dimerization between Ig-fold domains by domain-swapping mechanisms has been 
proposed in other proteins such as rat CD2 (Murray et al., 1995) and the human high 
affinity IgE receptor (Vangelista et al., 2002). However, in these cases, dimerization 
differs from that in Fve, in that it occurs by intertwining of the b-strands themselves that 



























Structural characterizations of 




Many proteins with platelet aggregation and blood coagulation effects have been purified 
from snake venoms.  They are a diverse group of molecules which differ in size and the 
mechanism of action.  A group of non-enzymatic proteins from this set have structural 
homology to CLPs (Ca2+-dependent lectin-like proteins). These proteins are generally 
heterodimers of MW ~30000 Daltons containing a disulfide bridge between the 2 
subunits.  Although they share significant sequence and structural similarity, they display 
varying effects on blood coagulation and platelet aggregation.  Some of these proteins, for 
example, bind coagulation factors X and/or IX such as ECLV IX/X-bp from Echis 
carinatus leucogaster venom (Chan et al., 1996), jararaca IX/X-bp from Bothrops 
jararaca venom (Sekiya et al., 1993), and habu IX/X-bp and IX-bp from Trimeresurus 
flavoviridis venom (Atoda et al., 1991 and Atoda et al., 1995). In contrast, bothrajaracin 
from Bothrops jararaca venom (Zingali et al., 1993) is a specific inhibitor of thrombin. 
A novel platelet aggregation inhibitor, rhodocetin, was purified from the crude 
venom of Calloselasma rhodostoma. It inhibited collagen-induced platelet aggregation in 
a dose-dependent manner, with an IC50 of 41 nM (Wang et al., 1999). The complete 
amino acid sequences of the a (15956.16 Da, 133 residues) and b (15185.10 Da, 129 
residues) subunits share a high degree of homology with each other (49% identity) and 
with the Ca2+-dependent lectin-like proteins (CLPs) (typically 29-46%) isolated from 
other snake venoms. Rhodocetin is a heterodimer, and individually both a and b subunits 
fail to show significant inhibition of aggregation (Wang et al., 1999). Unlike the other 
members of the CLP family in which the subunits are held together by an inter-chain 
disulfide bond, the subunits of rhodocetin are held together only by non-covalent 
interactions. The cysteinyl residues forming the inter-subunit disulfide bridge in all other 
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known CLPs are replaced by Ser 79 and Arg 75 in the a and b subunits of rhodocetin, 
respectively (Wang et al., 1999).  
We determined the three-dimensional structure of rhodocetin to understand 
structure-function relationships in this family of proteins.  
 
MATERIALS AND METHODS 
 
Protein purification  
Calloselasma rhodostoma crude venom (100 mg) was dissolved in 3.0 mL of 0.1 M 
ammonium hydrogen carbonate (pH 8.0) and centrifuged at 12000 rpm for 10 min at 4 ºC 
to remove particulate material. (a) The supernatant was then fractionated by a HiLoad 
Superdex 75 column (2.6 × 60 cm) equilibrated with the same buffer using a FPLC 
system. (b) The fractions from peak III (containing proteins of interest) were pooled and 
loaded directly onto a Mono Q HR 5/5 anion exchange column pre-equilibrated with 20 
mM Tris-HCl, pH 8.2. (c) Fractions from peak 2 of Mono Q were buffer exchanged with 
50 mM potassium phosphate, pH 7.0, containing 1.7 M ammonium sulfate (NAP-25 
column) before being loaded onto a Phenyl-Superose HR 5/5 column equilibrated with the 
same buffer. Elution was performed at a flow rate of 0.5 mL/min with a linear gradient of 
1.7-0.85 M ammonium sulfate in 50 mM potassium phosphate, pH 7.0, over 30 min.  
 
Protein crystallization and data collection  
Well-diffracting rhodocetin crystals were grown by vapor diffusion from hanging drops at 
0.7 M NaH2PO4, 0.7 M KH2PO4, 0.1 M HEPES-Na, pH 7.5 at 21 °C . Native crystals 
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were prepared by soaking the crystals in mother liquor containing 25% glycerol after 
which the crystals were flash-frozen at 100 K. Native data from a crystal was collected at 
the National Synchrotron Light Source (NSLS) beam line X8C at the wavelength 
0.978569 Å. The crystal diffracted to 1.9 Å. It belonged to the orthorhombic space group 
P212121 and had unit cell dimensions a = 46.875, b = 65.935, c = 118.841 Å and a = b = g 
= 90.0º. The data were processed and scaled using DENZO and SCALEPACK from the 
HKL2000 suite of programs (Otwinowski et al., 1997).  
 
Structure solution and refinement 
The structure was solved by the molecular replacement progam MOLREP (Vagin et al., 
1997). The A-chain of the coagulation factor IX-bp protein was chosen as a search model 
based on its high sequence identity to rhodocetin. The six N-terminal residues as well as 
residues 69 - 102 were deleted from the search model and two monomers were searched 
for in the asymmetric unit. A top peak was obtained after translation, with a correlation 
coefficient of 27.5%. The resulting electron density map revealed distinct secondary 
structure elements. The phases obtained by molecular replacement were directly used in 
ARP/wARP (Morris et al., 2002) for automated main chain tracing, which resulted in the 
building of six continuous fragments with connectivity index 0.95 that contained 245 
residues. The rest of the model and side chains were fitted manually using XtalView 
(McRee et al., 1999). Refinement was carried out with REFMAC5 (Murshudov et al., 
1999) using data in the resolution range of 30.00 Å- 1.9 Å and water molecules were 
identified using ARP/WARP later in the refinement. Data collection and refinement 
statistics are given in Table 3.1. The quality of the final model was verified with 
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Space group                   P212121 
Unit cell parameters (Å, °)       a = 46.87, b = 65.93, c = 118.84, a = b = g = 90.0 
Resolution range (Å)                       30.0 - 1.90  
Number of observed reflections             184500  
Number of unique reflections          28995 (2304)  
Redundancy        6.36 
Completeness (%)                            97.20 (78.7) 





Number of protein atoms                     2104 
Number of water molecules                 167 
 
R-factor                                        0.189 
Rfree (test set of 5%)                  0.231 
Data cutoff in s units            none  
RMS bond length                         0.020 
RMS bond angle                        1.672 
RMS chiral                                 0.175 
 
 











PROCHECK (Laskowski et al., 1993) (Figure 3.1). The Ramachandran plot shows that 
92.1% of the residues fall in the most favored region and the rest in the additional allowed 
region except the Thr 7 in the b subunit, which falls in the generously allowed region 
(Figure 3.2).  In total, two subunits: (1) a subunit with 132 residues (2) b subunit with 124 
residues and 168 solvent molecules were built into the high quality electron density map. 
The structure was refined at 1.9 Å to an R-factor of 18.9% and an R-free of 23.1%. The 
atomic co-ordinates and structure factors have been deposited in the Protein Data Bank 
(Berman et al., 2000) (PDB) as entry 1SB2. MolScript was used for molecular drawing. 
 
RESULT AND DISCUSSION 
 
Overall fold  
The rhodocetin dimer consists of two subunits, a and b containing 133 and 124 residues, 
respectively and shows 49 % identity with each other. Interestingly, the structure of the 
two subunits (a and b) superimpose almost perfectly except for the extended loop and the 
loop region following the first a-helix: the RMSD between their Ca atoms is 1.04 Å. In 
the a subunit, the loop region following the first a-helix forms a ?-turn, Gln 33 – Lys 35. 
In contrast to the a subunit, the loop region in the b subunit forms a b-turn, Ala 36 – Gly 
39. Each subunit contains 3 intra-subunit disulfide bonds: Cys 2 – Cys 13, Cys 30 – Cys 
127 and Cys 102 – Cys 119 in the a subunit; and Cys 4 – Cys 15, Cys 32 – Cys 123 and 
Cys 98 – Cys 115 in the b subunit. The disulfides in each subunit are found in similar 3D 




Figure 3.1. Electron density map. A portion of 2Fo-Fc map after the final refinement 








Figure 3.2. Thr 7 in the b subunit falls in the generously allowed region of the 







                    
 
 
Figure 3.3. Superposition of subunits.  The disulfides in each subunit are found in similar 
positions in the 3D structure. The a subunit is in red and b subunit in blue. Disulfide 
bonds are colored yellow.  
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The structure of rhodocetin comprises of a globular unit with an extended loop and 
forms a CLP fold. The a subunit contains eight b-strands and two a-helices, with seven 
strands forming two antiparallel b-sheets, while the b subunit contains seven b-strands, six 
forming two antiparallel b-sheets, and two a-helices. It is important to note that the b-
strand spanning four residues from Asn 80 to Ser 84 of a subunit runs antiparallel to the 
b-strand spanning four residues from Gly 71 to Arg 75 of  b subunit to form a two-
stranded b-sheet which is a critical secondary structure element for dimerization (Figure 
3.4). In addition to this b-sheet, the extended loops also form interactions. The backbone 
carbonyls of Gly 69, Asn 93 and Trp 114 in the a subunit form hydrogen bonds with the 
backbone amides of Thr 80, Trp 110 and Tyr 91 in the b subunit, while the backbone 
amides of Tyr 95 and Trp 114 in the a subunit form hydrogen bonds with the backbone 
carbonyls of Trp 110 and Asn 89 in the b subunit.  
 
Structure comparison with C-type lectins 
 A structure similarity search using the DALI (Holm et al., 1993) server indicated that the 
a and b subunits of rhodocetin belong to the C-type lectin super family. Eighteen known 
structures showed similarity to rhodocetin with a Z score > 2.0. In particular, IX/X-bp 
(Mizuno et al., 1997), lithostathine (Bertrand et al., 1996), CRD-4 (Feinberg et al., 2000) 
and tetranectine (Nielsen et al., 1997) were most similar, with Z scores > 13.0. 
Superposition of IX/X-bp, lithostathine, CRD-4 and tetranectine with rhodocetin revealed 
that major differences in their structure reside in the central loop region. The lithostathine 
and tetranectine are monomeric C-type lectin whereas IX/X-bp, CRD-4 and rhodocetin are
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Figure 3.4. Novel interface of rhodocetin. Residues from Asn 80 to Ser 84 of the a 
subunit run antiparallel to the b-strand spanning four residues from Gly 71 to Arg 75 of  
the b subunit to form a two-stranded b-sheet. This is a critical secondary structure element 




dimers. In a monomeric C-type lectin, the cental loop folds back into the body while in 
rhodocetin it forms an extended central loop from the body as seen in IX/X-bp and CRD-4 
(Mizuno et al., 1997). Furthermore, superposition of IX/X-bp of subunit A with 
rhodocetin a subunit shows that the significant deviation in the structure is due to the 
rotation of the loop by approximately 90º. The rotated loop spans 27 residues, from 
residue 73 to residue 100 (Figure 3.5). 
A comparison of the 3-Dimensional structures of the heterodimers, coagulation 
factor IX/X-bp, coagulation factor X-bp and botrocetin shows that only local differences 
exist between them, that are mainly due to insertions/deletions of residues. Besides, all the 
heterodimers are linked by a disulfide bond (Mizuno et al., 1999). In both coagulation 
factor IX/X-bp and X-bp, the inter-chain disulfide bond occurs between Cys 79A and Cys 
75B, while in botrocetin, it occurs between Cys 80A and Cys 75B. The residues in 
homologous positions to these Cys residues are Ser 79 and Arg 75 in the a and b subunits 
of rhodocetin, respectively (Wang et al., 1999). Moreover, rhodocetin has a unique 
interface as it lacks the canonical inter-subunit disulfide bridge. This novel interface of 
rhodocetin allows non-covalent interactions to compensate for the missing disulfide bond. 
There is an ordering of the loop regions from Asn 80 to Ser 84 of the a subunit and from 
Gly 71 to Arg 75 of the b subunit to create an extra b-sheet not previously observed in 
other CLPs at the interface. The backbone carbonyls of Asn 80A and Glu 82A form 
hydrogen bonds with the backbone amides of Arg 75B and Thr 73B, whereas the 
backbone amides of Glu 82A and Ser 84A participate in forming hydrogen bonds with the 
backbone carbonyls of Thr 73B and Gly 71B. It is most likely that this interface has 
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Figure 3.5. Superposition of IX/X-bp of subunit A with rhodocetin a subunit shows that 
the loop in rhodocetin spanning 27 residues is rotated by ~90º with respect to the similar 




disordered residues that create an ordered interface after interacting and subsequently 
present a surface that may then play a role in inhibiting platelet aggregation. 
 
Structure-function relationships 
Lack of metal binding site. Calcium ions are essential to the function and the 
crystallization of IX-bp protein. There are only a few examples of proteins crystallized 
without calcium ions that require Ca2+ to function. Intrinsic fluorescence analysis of IX/X-
bp in the presence of calcium ions indicated that Ca2+-binding induces conformational 
changes which stabilize the structure of the protein (Mizuno et al., 1999). In contrast 
inhibition of platelet aggregation by rhodocetin was shown to be independent of any metal 
ligand (Kong, 2002). Moreover, this protein can crystallize without metal ions. This 
indicates that rhodocetin does not need metal ligands to fold into an ordered structure in 
order to preserve its function. 
  The structural comparison of IX-bp, IX/X-bp and botrocetin Ca2+-binding residues 
with rhodocetin revealed some interesting features. The IX-bp and IX/X-bp showed that 
each subunit of these proteins had a Ca2+-binding site. In botrocetin, only the subunit B 
was bound to the divalent metal. Interestingly, both subunits of rhodocetin lost the ability 
to bind calcium ion. The loss of the metal ion binding site in A-subunit of botrocetin is 
due to the replacement of residues Glu 43 and Glu 128 in IX/X-bp and IX-bp with Lys 43 
and Lys 128 (Sen et al., 2001). In IX-bp and IX/X-bp, residues Ser 41, Glu 43, Glu 47 and 
Glu 128 in subunit A, and residues Ser 41, Gln 43, Glu 47 and Glu 120 in subunit B 
coordinate the binding of the calcium ions (Mizuno et al., 1999). In subunit a of 
rhodocetin residues Ser 41, Glu 43 and Glu 47 occupy the similar coordinate position of 
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IX/X-bp subunit A. However, the rhodocetin a subunit has Lys 128 instead of Glu 128 of 
IX/X-bp subunit A. In a similar manner, rhodocetin b subunit residues Gly 45 and Lys 124 
replace Gln 43 and Glu 120 of IX/X-bp subunit B, respectively (Figure 3.6). These 
substitution of Lys in both subunits of rhodocetin give raise to a positive charge instead of 
a negative charge and thus prevents the metal ion from binding rhodocetin by charge-
charge repulsion (Figure 3.7). Furthermore, the Lys 128 residue of a subunit is involved 
in the formation of a salt bridge with Glu 49, while the residue Lys 124 of the b subunit 
forms a salt bridge with Glu 47. These salt bridges could stabilize the fold in the absent of 
Ca2+-binding site, and hence form a functional CLP heterodimer protein. 
 
Differences to Eble rhodocetin. We have also clearly established that rhodocetin 
mentioned in this thesis as well as that of Wang et al., 1999 is a distinct entity from the 
rhodocetin reported by Eble et al., 2001. Rhodocetin reported by Eble et al. was in fact 
shown to be a dimer under nonreducing condition in SDS-PAGE, but fell upon reducing 
condition in SDS-PAGE. The Wang et al. rhodocetin protein exhibited two subunits in 
SDS-PAGE in the presence or absence of a reducing agent. We additionally note that the 
N-terminal amino acid sequence determined by Eble et al is different with respect to our 
sequence.  We checked the electron density, in particular, for residue 10 in the b subunit, 
and found that it corresponded to an Ala (consistent with our rhodocetin sequence), and 
not Met (in rhodocetin reported by Eble et al.).  The Eble rhodocetin protein had integrin 
binding activity which was not observed with our rhodocetin.  Therefore these molecules 
should be regarded as distinct entities. Structural comparison of the two similar rhodocetin 





             ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ....|....|  
                 5          15         25         35         45         55         65                        
IX/X-bp      DCLSGWSSYE GHCYKAFEKY KTWEDAERVC TEQAKGAHLV SIES-SGEAD FVAQLVTQNM KRLDFYIWIG  
IX-bp        DCPSGWSSYE GHCYKPFKLY KTWDDAERFC TEQAKGGHLV SIES-AGEAD FVAQLVTENI QNTKSYVWIG  
Botrocetin   DCPSGWSSYE GNCYKFFQQK MNWADAERFC SEQAKGGHLV SIKIYSKEKD FVGDLVTKNI QSSDLYAWIG  
Rhodocetin   DCPDGWSSTK SYCYRPFKEK KTWEEAERFC TEQEKEAHLV SMEN-RLEAV FVDMVMENNF ENKIYRSWIG  
 
             ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| .... 
                 75         85         95        105        115        125                     
IX/X-bp      LRVQGKVKQC NSEWSDGSSV SYENWIEAES KTCLGLEKET DFRKWVNIYC GQQNPFVCEA ---- 
IX-bp        LRVQGKEKQC SSEWSDGSSV SYENWIEAES KTCLGLEKET GFRKWVNIYC GQQNPFVCEA ---- 
Botrocetin   LRVENKEKQC SSEWSDGSSV SYENVVERTV KKCFALEKDL GFVLWINLYC AQKNPFVCKS PPP- 






                 5          15         25         35         45         55         65                 
IX/X-bp      --DCPSDWSS YEGHCYKPFS EPKNWADAEN FCTQQHAGGH LVSFQSSEEA DFVVKLAFQT FGHS--IFWM  
Ix-Bp        --DCPSDWSS YEGHCYKPFS EPKNWADAEN FCTQQHAGGH LVSFQSSEEA DFVVKLAFQT FGHS--IFWM  
Botrocetin   --DCPPDWSS YEGHCYRFFK EWMHWDDAEE FCTEQQTGAH LVSFQSKEEA DFVRSLTSEM LKGD--VVWI  
Rhodocetin   DFRCPTTWSA SKLYCYKPFK EKKTWIEAER FCAKQAENGH LVSIGSAAEA DFLDLVIVVN FDKQRYRAWT  
 
             ....|....| ....|....| ....|....| ....|....| ....|....| ....|....| ... 
                 75         85         95        105        115        125                     
IX/X-bp      GLSNVWNQCN WQWSNAAMLR YKAW--AEES YCVYFKSTN- -NKWRSRACR MMAQFVCEFQ A-- 
Ix-Bp        GLSNVWNQCN WQWSNAAMLR YKAW--AEES YCVYFKSTN- -NKWRSRACR MMAQFVCEFQ A-- 
Botrocetin   GLSDVWNKCR FEWTDGMEFD YDDYYLIAEY ECVASKPTN- -NKWWIIPCT RFKNFVCEFQ A-- 
Rhodocetin   GLT----ERN LKWTNGASVS YENLYEPYIR KCFVVQPWEG KSKWYKADCE EKNAFLCKFP KPH 
 
Figure 3.6. Sequence alignment of IX/X-bp, IX-bp and botrocetin with rhodocetin. (A) 
Alignment of A-chain. (B) Alignment of B-chain. The potential calcium binding residues 









                    
 
Figure 3.7. Geometry around the calcium binding site in CLPs. (A) Subunit A. (B) 
Subunit B. Superposition of the calcium ion coordination site in IX/X-bp (green) with the 
corresponding site in rhodocetin (blue). Glu 128A and Glu 120B of IX/X-bp are replaced 
by Lys 128 in the a subunit and Lys 124 in the b subunit, respectively. This substitution 






Dimerization by 3D domain swapping.  
The structure of rhodocetin clearly shows that the exchange of the extended loop region, 
between the a and b subunits indicates that dimerization is likely accomplished through 
3D swapping. If mannose-binding protein (Weis et al., 1991) is taken as the reference 
monomer as described for IX/X-bp (Mizuno et al., 1997), rhodocetin falls into the 
category of quasidomain-swapped dimer. Domain swapping in the C-type lectin 
superfamily is dominated by characteristic hydrophobic interactions. These specific 
interactions between the loop and the body of the adjoining subunit form the C-interface 
(Sen et al., 2001). In rhodocetin, the C-interface involves Leu 81, Trp 83, Ile 89, Tyr 91 
and Leu94 on the swapped loop of the a subunit, and Ile 44, Ala 47, Leu 72, Phe 99 and 
Trp110 on the body side of the b subunit (Figure 3.8). Likewise, the other C-interface 
consists of Leu 77, Trp 79, Val 85, Tyr 87 and Leu 90 on the swapped loop of the b 
subunit and the Ala 48, Leu 70, Ile 72, Phe 103 and Trp 114 on the body side of the a 
subunit. In addition to the hydrophobic interactions, hydrogen-bonding interactions are 
also observed in the C-interface: the a subunit carbonyl Asn 93 and amide Tyr 95 interact 
with the amide of Trp 110 and the carbonyl of Trp 110 of the b subunit, respectively. 
Similar structural features occur between the loop of the b subunit and the body of the a 
subunit.   
 The characterization of rhodocetin by gel filtration showed that it is a dimer in 
solution. Its two subunits are linked by non-covalent interactions. Both subunits are 
essential for the activity of rhodocetin; neither the a subunit nor the b subunit in isolation 
inhibits platelet aggregation (Wang et al., 1999). Topological comparison of the CLPs
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Figure 3.8. One of the C-interfaces of rhodocetin. Residues on the body side are indicated 







IX/X-bp, IX-bp, lithostathine, E-selectin, tetranectin and mannose-binding protein, 
showed that C-terminal side of the hinge loop in the dimers is six or more residues shorter 
than that of the the monomeric proteins. If a hinge loop is shortened by a deletion, then the 
closed monomer structure may no longer be possible in geometry and the resultant open 
monomer may be unstable because of the exposure of residues normally buried in the C-
interface. Domain-swapped dimers would then be favored (Mizuno et al., 1999 and 
Bennett et al., 1995). Comparison of the rhodocetin C-terminal side hinge loop with the 
mannose-binding protein revealed that the C-terminal side hinge loop of rhodocetin is six 
residues shorter than that of the monomeric protein. As a result, the central loop is 




Figure 3.9. Mannose-binding protein is taken as the reference monomer (A). Comparison 
of the rhodocetin C-terminal side hinge loop with the mannose-binding protein revealed 
that the C-terminal side hinge loop of rhodocetin is six residues shorter than that of the 
monomeric protein. As a result, the central loop is swapped and subsequently a functional 











































The golden needle mushroom, Flammulina velutipes, is a popular edible mushroom in the 
Orient, possessing anti-tumor, antiviral, antifungal and cholesterol-lowering activities. A 
major fruiting body protein, designated Fve or FIP-fve, was isolated and very likely plays 
a significant role in the mushroom’s immunomodulating effects. It stimulates mitogenesis 
of human peripheral lymphocytes, suppresses systemic anaphylaxis reactions and local 
swelling of mouse foot pads, and enhances the transcription of interleukin-2 (IL-2), 
interferon-g (IFN-g) and tumor necrosis factor-a (TNF-a).  In addition, it hemagglutinates 
human red blood cells. Fve is a non-covalently linked homodimer, each subunit 114 
amino acids in length. It contains no Cys, Met or His residues and its N-terminal Ser 
residues are acetylated. It shows sequence similarity only to other mushroom proteins with 
similar functional characteristics: LZ-8 (Ganoderma lucidum), Gts (Ganoderma tsugae), 
Vvo (Volvariella volvacea) and Vvl (Volvariella volvacea). All these proteins form the 
novel Fungal Immunomodulatory Protein (FIP) family. Furthermore, all dimers were 
thought to be formed by a mechanism called 3D domain swapping.  
Many proteins with platelet aggregation and blood coagulation effects have been 
purified from snake venoms.  They are a diverse group of molecules which differ in size 
and mechanism of action.  These proteins are generally heterodimers of MW ~30000 
containing a disulfide bridge between the 2 subunits.  Although they share significant 
sequence and structural similarity, they display varying effects on blood coagulation and 
platelet aggregation.  Some of these proteins, for example, bind coagulation factors X 
and/or IX such as ECLV IX/X-bp from Echis carinatus leucogaster venom, jararaca 
IX/X-bp from Bothrops jararaca venom, and habu IX/X-bp and IX-bp from Trimeresurus 
flavoviridis venom. In contrast, bothrajaracin from Bothrops jararaca venom is a specific 
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inhibitor of thrombin. A novel platelet aggregation inhibitor, rhodocetin, was purified 
from the crude venom of Calloselasma rhodostoma. It inhibited collagen-induced platelet 
aggregation in a dose-dependent manner. The complete amino acid sequences of the a 
(15956.16 Da, 133 residues) and b (15185.10 Da, 129 residues) subunits share a high 
degree of homology with each other (49% identity) and with the Ca2+-dependent lectin-
like proteins (CLPs) (typically 29-46%) isolated from other snake venoms. Rhodocetin is 
a heterodimer, and individually both a and b subunits fail to show significant inhibition of 
aggregation. Unlike the other members of the CLP family in which the subunits are held 
together by an inter-chain disulfide bond, the subunits of rhodocetin are held together only 
by non-covalent interactions. Rhodocetin heterodimer was believed to be formed by 
swapping the central loop. 
Although the functional details of both proteins, Fve and rhodocetin, were known 
prior to this study, structural information was unavailable. The structure of these proteins 
would be important to permit the understanding of the structure-function relationships.  
The structure of Fve, was determined by Single Anomalous Diffraction (SAD) 
using the anomalous signal of bromide ions present in the crystal for phasing. Fve 
represents a novel structure, wherein each subunit of the homodimer consists of an N-
terminal a-helix followed by a fibronectin III (FNIII) type fold. The FNIII fold is the first 
instance of “pseudo-h-type” topology – a transition between the seven b-stranded s-type 
and the eight b-stranded h-type topologies. Fve does not contain tyrosine corner, which is 
found in >90% of (even sequence-unrelated) FNIII and Ig variable domains, but 
interestingly, this critical need is satisfied by the type I b-turn (Ala86-Asp-Thr-Lys89), 
with the backbone C=O of Ala86 forming an H-bond with the backbone N atom of Lys89. 
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The overall structure suggests that dimerization, critical for the activity of FIP proteins, 
occurs by 3D domain swapping of the N-terminal helices and is stabilized predominantly 
by strong hydrophobic interactions. Several simple sugars tested did not inhibit Fve-
induced hemagglutination. However, the highly glycosylated protein thyroglobulin was 
found to inhibit hemagglutination, suggesting that Fve is a lectin with specificity for 
complex cell surface carbohydrates. We have predicted two pairs of patches that offer the 
potential to bind sugars. The first pair is found on the same side of the dimer. The second 
patch is found on opposite sides of the dimer. The structure of Fve is the first 
representative of this structurally novel family of lectins. It is also, to the best of our 
knowledge, the first structure of an FNIII domain-containing protein of fungal origin. 
The structure of rhodocetin was determined by molecular replacement.  This is the 
first structure of a CLP without a disulfide connecting the subunits and thus represents a 
novel molecule. The structure of rhodocetin comprises of a globular unit with an extended 
loop and forms a CLP fold. Superposition of IX/X-bp of subunit A with rhodocetin a 
subunit shows that the significant deviation in structure is due to the rotation of the loop 
by approximately 90º. The rotated loop spans 27 residues, from residue 73 to residue 100. 
The structure reveals the inter-subunit interface which has compensatory interactions for 
forming the dimer in the absence of the disulfide bridge. There is an ordering of the loop 
regions from Asn 80 to Ser 84 of the a subunit and from Gly 71 to Arg 75 of the b subunit 
to create an extra b-sheet not previously observed in other CLPs at the interface. It is most 
likely that this interface has disordered residues which create an ordered interface after 
interacting and subsequently present a surface which may then play a role in inhibiting 
platelet aggregation. Further, unlike other CLPs, rhodocetin does not require metal ions 
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for its functional activity. However, like other CLPs, rhodocetin also forms the 
heterodimer by domain swapping, in which the central looped region is swapped.  
The structure of Fve and rhodocetin suggest that both dimers are formed by 3D 
domain swapping process. Both proteins are inactive in monomeric forms and hence the 
occurrence of dimerization is essential for the biological activity of the proteins by 
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